Type
. A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. Vaccine. 2019;.
Type
. Expansion and suppressive capacity of regulatory T cells isolated from patients across the leprosy spectrum: a pilot study. Microbes and infection. 2019;.
Type
. Current updates on dental perspectives of leprosy - Revisited. Disease-a-month : DM. 2019;:100918.
Type
. Oral candida prevalence and species specificity in leprosy. Disease-a-month : DM. 2019;:100920.
Type
. Hematological alterations in lepromatous leprosy: A cross-sectional observational study. Disease-a-month : DM. 2019;:100919.
Type
. Lepromatous leprosy, melanoma, and basal cell carcinoma: clinical-histopathologic association. Anais brasileiros de dermatologia. 2019;94(5):586-589.
Type
. Trend of leprosy detection rate in Brazil, 1990 to 2016. Anais brasileiros de dermatologia [Internet]. 2019;94(5):603-607. Available from: https://www.sciencedirect.com/science/article/pii/S0365059619300480?via%3Dihub
Type
. PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil. Immunobiology. 2019;.
Type
. Scoping Review: Community Programs for People with Leprosy. Tropical medicine & international health : TM & IH. 2019;.
Type
. Knowledge on leprosy and its management among primary healthcare providers in two districts of Bangladesh. BMC health services research. 2019;19(1):787.